Kekkan Biologics
Strasbourg, France · kekkan-biologics.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Kekkan Biologics develops first-in-class biologics for severe neovascular, fibrotic, and hard-to-treat cancer indications. It is based in Strasbourg, France, and is a spin-off from the laboratory of Dr. Gilles Pagès at the University of Nice Côte d’Azur and IRCAN.
Their website has a general contact form; we send your quote request through it.
What they offer
Target identification platform
Identifies new therapeutic targets through a proprietary translational target selection platform.
Antibody development
Develops antibodies using a proprietary antibody development platform.
Discovery of new biologics
Discovers and develops new specific biologics based on its proprietary technology platform.
Translational drug design
Designs novel biologics using a translational drug design platform.
Target validation
Supports target validation for therapeutic programs.
In vitro proof-of-concept studies
Conducts in vitro proof-of-concept studies for early-stage programs.
In vivo proof-of-concept studies
Conducts in vivo proof-of-concept studies for early-stage programs.
What they work on
- Modalities
- Small molecule, Antibody, Bispecific, ADC, Cell therapy
- Assays and studies
- target validation, in vitro proof-of-concept, in vivo proof-of-concept
- Therapeutic areas
- cancer, fibrotic disorders, neovascular disorders, lymphangiogenesis, tumor angiogenesis, immunology
- Sites
- Strasbourg, France
Similar labs. Biocytogen, Oncodesign Services, Aurigene Pharmaceutical Services, Evotec
Found in a contract services directory. Listing built from kekkan-biologics.com. Work here? Claim this listing.